Pentobarbital will decrease the level or effect of aripiprazole by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch. pentobarbital will decrease the extent or influence of buprenorphine subdermal implant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Carefully. Check clients presently on buprenorphine subdermal implant who have t... https://anatolea791xtm9.ltfblog.com/profile